ArticleNano convergence2026

Multimodal gene and targeted drug therapy for chronic myelogenous leukemia using BIM/MCL-1 chimeric nanoparticle: computational target analysis and therapeutic validation.

Margaret L Lugin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.